Skip to content
Screener

Sutro Biopharma STRO Cash Flow Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
-$31.49M+44.6%-$38.53M-235%-$38.48M+49.3%-$46.76M+35.4%-$56.86M-16.5%
$1.24M-34.5%$1.26M-33.6%$1.28M-32.7%$1.62M-13.1%$1.9M+5.6%
$2.16M+38.9%$2.01M-61.8%$1.56M-71.8%$1.66M-72.0%$1.55M-76.3%
-$22.45M+41.2%-$38.29M+14.4%-$42.26M+37.7%-$26.44M+63.2%-$38.19M+40.8%
——$256K—$0-100%——$47K-91.5%
————-$45.26M-178%$18.7M-78.6%$39.99M-72.9%
——————————
$133K+30.4%——$103.08M+156,074%——$102K-90.0%
-$7.48M—-$19.35M+54.2%$15.55M+118%-$7.8M-150%$0-100%
-$22.37M+41.5%-$38.55M+13.8%-$42.26M+37.8%-$26.38M+63.2%-$38.24M+41.2%

FAQ

How much cash does Sutro Biopharma generate?
Sutro Biopharma (STRO) generated -$129.4M in operating cash flow over the trailing twelve months.
What is Sutro Biopharma's free cash flow?
Sutro Biopharma's free cash flow was -$129.6M over the trailing twelve months, up 41.8% year over year.
Where does Sutro Biopharma's cash flow data come from?
Every line is extracted from Sutro Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.